NCT04967079 2024-04-23Trametinib Plus Anlotinib in Non-G12C KRAS-Mutant NSCLC PatientsShanghai Chest HospitalPhase 1 Completed33 enrolled
NCT03910127 2019-10-30Study of TQB2450 Combined With Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 1 Unknown90 enrolled